Sector: MedicalEPICEPT CORPORATION (NASDAQ: EPCT)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 142 |
Technical : | 180 |
Performance : | 178 |
Overall: | 186 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 150 |
Technical : | 100 |
Performance : | 191 |
Overall: | 146 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 142 |
Technical : | 115 |
Performance : | 192 |
Overall: | 158 |
Number of Stocks: | 306 |
Headlines
- EpiCept Corporation Reports Third Quarter Results, Provides Business Update
Nov 10, 2009 12:01 AM | EPCT
- EpiCept Corporation Announces Health Canada Accepts Ceplene(R) Application for Review
Nov 09, 2009 12:01 AM | EPCT
- EpiCept Corporation Names Bernard Tyrrell as Senior Vice President, Sales and Marketing
Nov 06, 2009 12:01 AM | AZN, EPCT, JNJ, LLY
- EpiCept to Report Third Quarter 2009 Operating and Financial Results on November 10, 2009
Nov 05, 2009 12:01 AM | EPCT
- EpiCept to Present at BIO-Europe 2009
Nov 02, 2009 06:15 PM | EPCT
- New Data Supports Pharmacoeconomic Benefits of Ceplene(R)
Oct 26, 2009 12:01 AM | EPCT
- EpiCept's Ceplene(R) Highlighted in Two 2008 European Union Drug Approval Reports
Sep 03, 2009 12:01 AM | EPCT
- EpiCept Corporation to Present at the Rodman & Renshaw Healthcare Conference
Sep 02, 2009 12:01 AM | EPCT
- EpiCept Corporation Provides Third Quarter Results
Nov 07, 2008 07:52 PM | EPCT
- The Week in Review: Summer Slump for News
Jul 27, 2008 01:57 PM | EPCT, GNLB, GSK
- EpiCept Corporation Reports Third Quarter Results,Provides Business Update
Nov 10, 2009 12:53 AM | EPCT, MYGN
- Nasdaq Panel Grants EpiCept's Request for Continued Listing
Nov 03, 2009 12:52 AM | EPCT, MYGN
- BioMed Realty Trust Commemorates Five-Year Anniversary As a Public Company ; Ringing NYSE Closing Bell(R) Today; Provides Tenant Update
Aug 06, 2009 06:53 AM | ARNA, AVII, AZN, BMR, CEPH, EPCT
- EpiCept Corporation Reports Second Quarter 2009 Operating and Financial Results, Provides Business Update
Aug 06, 2009 01:37 AM | EPCT, MYGN
- EpiCept Announces Filing of New Drug Submission for Approval of Ceplene in Canada
Aug 05, 2009 12:03 AM | EPCT
- EpiCept to Report Second Quarter 2009 Operating and Financial Results on August 6, 2009
Aug 03, 2009 12:02 AM | EPCT
- EpiCept Initiates Post-Approval Clinical Study with Ceplene®
Jul 10, 2009 12:02 AM | EPCT
- EpiCept Announces Results of Annual Meeting of Stockholders
Jul 03, 2009 12:02 AM | EPCT
- EpiCept Shares on the OMX Nordic Exchange Transferred Back to Ordinary Position From Observation Segment
Jun 29, 2009 12:53 AM | EPCT, MYGN
- EpiCept Announces Pricing of Public Offering
Jun 19, 2009 01:52 PM | EPCT, RODM
- Form 4 Tyrrell Bernard R For: Nov 04 (10K)
Nov 06, 2009 11:59 AM
- Form 3 Tyrrell Bernard R For: Nov 04 (10K)
Nov 06, 2009 11:46 AM
- Form 4 Smyth A. Collier For: Jun 02 (10K)
Jun 04, 2009 08:52 PM
- Form 4 Jackson Guy C. For: Jun 02 (10K)
Jun 04, 2009 07:58 PM
- Form 4 Yetter Wayne P. For: Jun 02 (10K)
Jun 04, 2009 07:45 PM
- Form 4 Waldheim Gerhard For: Jun 02 (10K)
Jun 04, 2009 07:34 PM
- Form 4 Savage Robert G. For: Jun 02 (10K)
Jun 04, 2009 07:21 PM
- Form 4 Smyth A. Collier For: Apr 08 (10K)
Apr 10, 2009 02:12 PM
- Form 3 Smyth A. Collier For: Apr 08 (10K)
Apr 10, 2009 01:30 PM
- Form 4 Talley John V. For: Feb 20 (10K)
Feb 24, 2009 08:48 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
EPCT
|
Compare to S&P
|
| YTD |
12.50 %
|
-6.89 %
|
| 4 Weeks |
-17.24 %
|
-18.14 %
|
| 12 Weeks |
-4.00 %
|
-9.49 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 33.33 %
|
|
EPS Growth in Last Year: 55.56 %
|
|
Sales Growth in Last Quarter: 27.47 %
|
|
Sales Growth in Last Quarter: 48.72 %
|
|
